pubmed.ncbi.nlm.nih.gov

Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study - PubMed

  • ️Thu Jan 01 2009

Comparative Study

. 2009 Jan 1;169(1):105-12.

doi: 10.1093/aje/kwn287. Epub 2008 Oct 30.

Affiliations

Comparative Study

Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study

Penelope P Howards et al. Am J Epidemiol. 2009.

Abstract

Planning study visits during specific menstrual cycle phases is important if the exposure or outcome is influenced by hormonal variation. However, hormone profiles differ across cycles and across women. The value of using fertility monitors to time clinic visits was evaluated in the BioCycle Study (2005-2007). Women aged 18-44 years (mean, 27.4) with self-reported menstrual cycle lengths of 21-35 days were recruited in Buffalo, New York, for 2 cycles (n = 250). Participants were provided with home fertility monitors that measured urinary estrone-3-glucuronide and luteinizing hormone (LH). The women were instructed to visit the clinic for a blood draw when the monitor indicated an LH surge. The monitor recorded a surge during 76% of the first cycles and 78% of the second cycles. Scheduling visits by using set cycle days or algorithms based on cycle length, such as a midcycle window or a window determined by assuming a fixed luteal phase length, would be simpler. However, even with perfect attendance in a 3-day window, these methods would have performed poorly, capturing the monitor-detected LH surge only 37%-57% of the time. Fertility monitors appear to be useful in timing clinic visits in a compliant population with flexible schedules.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.

Estrogen, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and progesterone levels during an idealized 28-day menstrual cycle with the LH surge around day 14.

Similar articles

Cited by

References

    1. Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev. 1995;17(2):265–286. - PubMed
    1. Rosenberg CR, Pasternack BS, Shore RE, et al. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol. 1994;140(6):518–525. - PubMed
    1. Yu H, Shu XO, Shi R, et al. Plasma sex steroid hormones and breast cancer risk in Chinese women. Int J Cancer. 2003;105(1):92–97. - PubMed
    1. Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst. 1996;88(16):1127–1135. - PubMed
    1. Ahmad N, Pollard TM, Unwin N. The optimal timing of blood collection during the menstrual cycle for the assessment of endogenous sex hormones: can interindividual differences in levels over the whole cycle be assessed on a single day? Cancer Epidemiol Biomarkers Prev. 2002;11(1):147–151. - PubMed

Publication types

MeSH terms

Substances